_mesenchymal-stem-cells-in-cell-and-gene-therapy-the-immunomodulatory-properties-of-mscs-preview-1.jpg "Mesenchymal stem cells in cell and gene therapy – the immunomodulatory properties of MSCs from immunomodulatory therapy Video Screenshot Preview 1")
Gallery_mesenchymal-stem-cells-in-cell-and-gene-therapy-the-immunomodulatory-properties-of-mscs-preview-3.jpg "Mesenchymal stem cells in cell and gene therapy – the immunomodulatory properties of MSCs from immunomodulatory therapy Video Screenshot Preview 3")
Gallery_mesenchymal-stem-cells-in-cell-and-gene-therapy-the-immunomodulatory-properties-of-mscs-preview-hqdefault.jpg "Mesenchymal stem cells in cell and gene therapy – the immunomodulatory properties of MSCs from immunomodulatory therapy Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 2 minutes 26 seconds
👁 View: 1.8K times
Play Audio:👁 View: 1.8K times
Description:
PromoCell
PromoCell
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_autologous-msc-ntf-cells-may-activate-neuroprotective-and-immunomodulatory-pathways.webp "BrainStorm Cell Therapeutics (NASDAQ: BCLI) is a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases. BrainStorm’s NurOwn® technology platform differentiates a patient’s own bone marrow-derived mesenchymal stem cells to create autologous mesenchymal stem cells secreting neurotrophic-factors (MSC-NTF cells).The autologous MSC-NTF cells are injected into the patient’s cerebrospinal fluid through intrathecal administration where th")
⏲ 33 sec ✓ 16-Apr-2019
_immunomodulators-part-1-immunosuppressants.webp "Professor Dave Explains")
_proven-benefits-of-probiotics-during-pregnancy-and-breastfeeding.webp "Can Probiotics Really Treat Lactational Mastitis? nLactational mastitis is an infection of one or more lobules of the mammary gland, occurring up to 33% of lactating mothers. Although the condition may happen at any point during the lactation period, between 75-95% of cases occur within the first 12 weeks, with the frequency particularly higher during the second and third weeks postpartum. nnNew research shows that lactational mastitis is a dysbiotic process. Significant levels of beneficial mic")
_immunomodulatory-drugs.webp "Myeloma UK")
_treating-ibd-immunomodulators.webp "Crohn's u0026 Colitis Foundation")
_ido1-indoleamine-23-dioxygenase.webp "IDO1 is an immunosuppressive enzyme that leads to regulatory T-cell generation and activation, and allows tumors to escape from immune surveillance.nnInhibition of immunomodulatory mechanisms with IDO1 inhibitor-based combination therapy may re-establish anti-tumor immunity.")
_autologous-msc-ntf-cells-may-activate-neuroprotective-and-immunomodulatory-pathways.jpg)
_immunomodulators-part-1-immunosuppressants.jpg)
_proven-benefits-of-probiotics-during-pregnancy-and-breastfeeding.jpg)
_immunomodulatory-drugs.jpg)
_treating-ibd-immunomodulators.jpg)
_ido1-indoleamine-23-dioxygenase.jpg)
![[+]](/images/menu.gif){kind=small}